Contact Us
INNOGLY INNOGLY INNOGLY INNOGLY
Navigation
  • About us
    • COST Action
    • Network members
    • Scientific Outputs
      • Scientific Publications
      • Abstracts from Events
  • News
  • Events
  • Working Groups
    • Development and Cancer
    • Autophagy
    • Immunity
    • GAGs
  • STSM
    • STSM information
    • STSM proposal
    • STSM evaluation
    • Awarded STSMs
  • ITC Grants
  • Training Schools

Logged out

Lost Password?

News

Training School on the Conjugation of Glycans onto Nanomaterials
The COST action "INNOGLY" (Innovation with glycans: new frontiers from ...
Read More
Glycosaminoglycan Interaction Networks and Databases
The article GLYCOSAMINOGLYCAN INTERACTION NETWORKS AND DATABASES , by Sylvie Ricard Blum and ...
Read More
INNOGLY Annual Meeting 2022 (4-6 May Lugano)
4-6 May 2022, Lugano, Switzerland The Annual Meeting of the INNOGLY ...
Read More
Exploring the Multifaceted Roles of Glycosaminoglycans (GAGs): Special Issue Reprint
Read More
GlycosAminoGlycans: What remains to be solved?
  Scientific and Organizing Committee: Dragana Nikitovic & Serge Perez Topical organizing ...
Read More

WG1-WG3 Joint Meeting “Glycosylation in Cancer and Tumour Immunology”

Dates: 8th and 9th October 2020
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto,
Porto, Portugal and Virtual Conference
Organizers:
Ana Magalhães
Barbara Richichi
Celso A. Reis
Programme:
Indicated times are Western European Summer Time (West Time).
8th October (Thursday)
14h00-14h30 – Registration
14h30-14h45 – Welcome Session (Barbara Richichi and Celso A. Reis)
> Session I
Chair: Celso A. Reis
14h45-15h05 – Keynote lecture KL1-Robert Sackstein (15+5 min) – Glycan Determinants in Cancer as Targets for CAR-T-cell-based Therapeutics
15h05-15h25 – Keynote lecture KL2-Sandra van Vliet (15+5 min) – FUT9-Driven Programming of Colon Cancer Cells Towards a Stem Cell-Like State
15h25-15h55 –Selected Communications
SC1 – José Reina Martin (8+2 min) – Selectins Ligands to Target Endothelial Cells Surrounding Metastatic Tumors
SC2 – Kristina A. Thomsson (8+2 min) – O-glycan sulfation on ovarian cancer cyst fluid mucin-type proteins
SC3 – Tomasz Kobiela (8+2 min) – Characterization of cell-surface glycans interactions with lectins as test for melanoma development
16h00 – 16h30 – Coffee-Break
16h30-19h00 – MC Meeting (Chair: Luigi Lay)
9th October (Friday)
> Session II
Chair: Ana Magalhães
9h15-9h35 – Keynote lecture KL3 – Bernadette Tse Sum Bui (15+5 min) – Molecularly Imprinted Polymers: Chemical Antibody Mimics for Clinical Diagnosis and Therapy
9h35-9h55 – Keynote lecture KL4 – Niclas Karlsson (15+5 min) – Gastric O-glycomic discovery is revealing surprises regarding H. pylori interaction
9h55-10h20 – Selected Communications
SC4 – Angelina Palma (8+2 min) – Sialyl ligands other than the α2,6-sialyl-Tn O-glycan identified for human Siglec-15
SC5 – Dragana Nikitovic (8+2 min) – Lumican stimulates chondrosarcoma cell growth by regulating IGF-IR activity
10h30 – 11h00 – Coffee-Break
> Session III
Chair: Barbara Richichi
11h00-11h20 – Keynote lecture KL5- Anne Harduin-Lepers (15+5 min) – B4GALNT2 controls Sda and sLex antigens biosynthesis in healthy and cancer human colon
11h20-11h40 – Keynote lecture KL6 –Ramon Hurtado Guerrero (15+5 min) – Structural basis for substrate specificity and catalysis of α1,6-fucosyltransferase
11h40-12h10 – Selected Communications
SC6 – Fumiichiro Yamamoto (8+2 min) – ABO Blood Groups in Immunology and Cancer
SC7 – Matjaz Weiss (8+2 min) – In vitro modulation of protein O-GlcNAcylation and its impact on dendritic cells function
12h10- 12h30 – Keynote lecturer KL7- Ruben Ragg (15+5 min) – Getting Published in 2020 and Beyond: How to Adapt to a Rapidly Changing Publication Landscape
12h30 – 12h50 – Closing session (Barbara Richichi, Celso A. Reis, Luigi Lay)

October 7, 2020

Events

Training School on the Conjugation of Glycans onto Nanomaterials
The COST action "INNOGLY" (Innovation with glycans: new frontiers from ...
Read More
WORKSHOP “Neuroglycoproteins in Health and Disease” 24-25 March 2022 Alicante (Spain)
Read More
INNOGLY Annual Meeting 2022 (4-6 May Lugano)
4-6 May 2022, Lugano, Switzerland The Annual Meeting of the INNOGLY ...
Read More

Follow us on Twitter


Follow INNOGLY

Twitter Timeline

RT @FedeCompos: An overview on alternative/innovative methodologies for glycosidic bond formation in our latest review on @CarbohydrateRes…

RT @dr_inclan: I’ve remade this old animation to show the aqueous core of the liposome as the lipid bilayer disappears.
Using #geometrynode…

RT @bmmc_9: 📢It is our pleasure to announce that the Scientific Programme is now available online.
Follow the link for more details: https…

RT @GarozzoDomenico: Un viaggio nel fantastico mondo dei glicani | CNR. It was an amazing duet conference (in Italian) with @MolinaroTony o…

RT @IainWil92988866: Serge Perez @Glycopedia talks about hierarchies in starch structure – remarkable beauty at microscopic and molecular l…

POLICY STATEMENT:

Biomedicine and Molecular Biosciences Action CA18103 is funded by COST, which is supported by the EU Framework Programme Horizon 2020.

COST Action CA18103

© Copyright 2022. All Rights Reserved | Powered by innogly.eu | Designed by AWA
  • Imprint
  • /
  • Privacy policy
  • /
  • Cookie Policy (EU)
  • /
Manage Cookie Consent
We use cookies to optimize our website and our service.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
Preferences
{title} {title} {title}